Dataset: Transcription profiling by array of human cancer cell lines resistant to methotrexate
This SuperSeries is composed of the following subset Series:; GSE11440: Role of Caveolin 1, E-Cadherin, Enolase 2 and PKCa on resistance...
This SuperSeries is composed of the following subset Series:; GSE11440: Role of Caveolin 1, E-Cadherin, Enolase 2 and PKCa on resistance to methotrexate in human HT29 colon cancer cells; GSE16066: Networking of differentially expressed genes in CaCo2 human colon cancer cells resistant to methotrexate; GSE16070: Networking of differentially expressed genes in human MCF7 breast cancer cells resistant to methotrexate; GSE16080: Networking of differentially expressed genes in human MDA-MB-468 breast cancer cells resistant to methotrexate; GSE16082: Networking of differentially expressed genes in human MIA PaCa2 pancreatic cancer cells resistant to methotrexate; GSE16085: Networking of differentially expressed genes in human K562 erythtoblastic leukemia cells resistant to methotrexate; GSE16089: Networking of differentially expressed genes in human Saos-2 osteosarcoma cells resistant to methotrexate Experiment Overall Design: Refer to individual Series
- Species:
- human
- Samples:
- 42
- Source:
- E-GEOD-16648
- PubMed:
- 19732436
- Updated:
- Dec.12, 2014
- Registered:
- Sep.12, 2014
Sample | disease state | cell line | phenotype |
---|---|---|---|
GSM28849 | colon cancer | HT29 | methotrexate sensitive |
GSM28849 | colon cancer | HT29 | methotrexate sensitive |
GSM28849 | colon cancer | HT29 | methotrexate sensitive |
GSM28850 | colon cancer | HT29 | methotrexate resistant |
GSM28850 | colon cancer | HT29 | methotrexate resistant |
GSM28850 | colon cancer | HT29 | methotrexate resistant |
GSM402370 | colon cancer | Caco2 | methotrexate sensitive |
GSM402370 | colon cancer | Caco2 | methotrexate sensitive |
GSM402370 | colon cancer | Caco2 | methotrexate sensitive |
GSM402378 | colon cancer | Caco2 | methotrexate resistant |
GSM402378 | colon cancer | Caco2 | methotrexate resistant |
GSM402378 | colon cancer | Caco2 | methotrexate resistant |
GSM402417 | breast cancer | MCF7 | methotrexate sensitive |
GSM402417 | breast cancer | MCF7 | methotrexate sensitive |
GSM402417 | breast cancer | MCF7 | methotrexate sensitive |
GSM402420 | breast cancer | MCF7 | methotrexate resistant |
GSM402420 | breast cancer | MCF7 | methotrexate resistant |
GSM402420 | breast cancer | MCF7 | methotrexate resistant |
GSM402520 | breast cancer | MDA-MB-468 | methotrexate sensitive |
GSM402520 | breast cancer | MDA-MB-468 | methotrexate sensitive |
GSM402520 | breast cancer | MDA-MB-468 | methotrexate sensitive |
GSM402526 | breast cancer | MDA-MB-468 | methotrexate resistant |
GSM402526 | breast cancer | MDA-MB-468 | methotrexate resistant |
GSM402526 | breast cancer | MDA-MB-468 | methotrexate resistant |
GSM402529 | pancreatic cancer | MIA PaCa2 | methotrexate sensitive |
GSM402529 | pancreatic cancer | MIA PaCa2 | methotrexate sensitive |
GSM402529 | pancreatic cancer | MIA PaCa2 | methotrexate sensitive |
GSM402533 | pancreatic cancer | MIA PaCa2 | methotrexate resistant |
GSM402533 | pancreatic cancer | MIA PaCa2 | methotrexate resistant |
GSM402533 | pancreatic cancer | MIA PaCa2 | methotrexate resistant |
GSM402560 | erythroblastic leukemia | K562 | methotrexate sensitive |
GSM402560 | erythroblastic leukemia | K562 | methotrexate sensitive |
GSM402560 | erythroblastic leukemia | K562 | methotrexate sensitive |
GSM402652 | erythroblastic leukemia | K562 | methotrexate resistant |
GSM402652 | erythroblastic leukemia | K562 | methotrexate resistant |
GSM402652 | erythroblastic leukemia | K562 | methotrexate resistant |
GSM402655 | osteosarcoma | Saos-2 | methotrexate sensitive |
GSM402655 | osteosarcoma | Saos-2 | methotrexate sensitive |
GSM402655 | osteosarcoma | Saos-2 | methotrexate sensitive |
GSM40268 | osteosarcoma | Saos-2 | methotrexate resistant |
GSM40268 | osteosarcoma | Saos-2 | methotrexate resistant |
GSM40268 | osteosarcoma | Saos-2 | methotrexate resistant |